Journal of Immunology Research

Clinical and Experimental Immunomodulation 2016


Status
Published

Lead Editor

1National Institute of Psychiatry, Mexico City, Mexico

2Institute of Physiology and Pathophysiology, Marburg, Germany

3Universidad Nacional de Rosario, Rosario, Argentina

4Universidad Nacional Autonoma de México, Mexico City, Mexico

5Institute of Biomedical Research, Porto Alegre, Brazil


Clinical and Experimental Immunomodulation 2016

Description

The proper functions of cells, receptors, and soluble mediators are essential for adequate immune responses and, thus, those functions are often altered in diseases. Hyper- or hyporeactive immune responses are associated with broad-spectrum diseases, like chronic inflammatory diseases, infections, allergies, autoimmune diseases, and immunodeficiencies. Several elements can contribute to the deregulation of the immune response, including genetic and environmental factors, as well as the individual's perception.

In recent years, an immunomodulatory effect of apparently unrelated molecules such as hormones and neurotransmitters on the immune response has been reported, leading to the identification of potential therapeutic targets. For these reasons the investigation of the effect of small molecules, organic compounds, antigenic sources, or even cells with immunomodulatory properties promises the development of new therapies for a wide range of ailments.

We invite authors to submit original research and review articles that analyze the immunomodulatory effects of classical and nonclassical molecules and compounds on clinical and experimental models as a therapeutic approach for chronic inflammatory diseases, infections, allergies, autoimmune diseases, and immunodeficiencies.

Potential topics include but are not limited to the following:

  • Modulation of immune response by the following:
    • Neurotransmitters
    • Hormones
    • Acute or chronic stress
    • Extracts from microorganisms or similar compounds
    • Antibodies
    • Cytokines, soluble receptors, and related molecules
    • Biodrugs
    • New or experimental immunosuppressant drugs

Articles

  • Special Issue
  • - Volume 2016
  • - Article ID 2419621
  • - Research Article

PD-1/PD-L1 Interaction Maintains Allogeneic Immune Tolerance Induced by Administration of Ultraviolet B-Irradiated Immature Dendritic Cells

Lanfang Zhang | Chang-Qing Xia
  • Special Issue
  • - Volume 2016
  • - Article ID 5730674
  • - Review Article

Effects of Adoptive Transfer of Tolerogenic Dendritic Cells on Allograft Survival in Organ Transplantation Models: An Overview of Systematic Reviews

Yanni Zhou | Juan Shan | ... | Li Feng
  • Special Issue
  • - Volume 2016
  • - Article ID 7121580
  • - Review Article

Mesenchymal Stem Cells and Myeloid Derived Suppressor Cells: Common Traits in Immune Regulation

Irina Lyadova Vladimirovna | Ekaterina Sosunova | ... | Tatiana Nenasheva
  • Special Issue
  • - Volume 2016
  • - Article ID 7402760
  • - Research Article

Lactobacillus rhamnosus GG Activation of Dendritic Cells and Neutrophils Depends on the Dose and Time of Exposure

Shirong Cai | Matheswaran Kandasamy | ... | Ratha Mahendran
  • Special Issue
  • - Volume 2016
  • - Article ID 8426874
  • - Review Article

An Update on Inflamm-Aging: Mechanisms, Prevention, and Treatment

Shijin Xia | Xinyan Zhang | ... | Xiantao Tai
  • Special Issue
  • - Volume 2016
  • - Article ID 1058165
  • - Research Article

CD3+CD8+CD28 T Lymphocytes in Patients with Lupus Nephritis

Marcelina Żabińska | Magdalena Krajewska | ... | Marian Klinger
  • Special Issue
  • - Volume 2016
  • - Article ID 6530410
  • - Research Article

Tumor-Derived CXCL1 Promotes Lung Cancer Growth via Recruitment of Tumor-Associated Neutrophils

Ming Yuan | Ha Zhu | ... | Qiuyan Liu
  • Special Issue
  • - Volume 2016
  • - Article ID 1280347
  • - Research Article

Low-Dose Oxygen Enhances Macrophage-Derived Bacterial Clearance following Cigarette Smoke Exposure

William G. Bain | Ashutosh Tripathi | ... | Neil R. Aggarwal
  • Special Issue
  • - Volume 2016
  • - Article ID 9697080
  • - Clinical Study

New Alternatives for Autoimmune Disease Treatments: Physicochemical and Clinical Comparability of Biosimilar Etanercept

Mariana P. Miranda-Hernández | Carlos A. López-Morales | ... | Emilio Medina-Rivero
  • Special Issue
  • - Volume 2016
  • - Article ID 6031486
  • - Research Article

Monocyte Differentiation towards Protumor Activity Does Not Correlate with M1 or M2 Phenotypes

G. Karina Chimal-Ramírez | Nancy Adriana Espinoza-Sánchez | ... | Ezequiel M. Fuentes-Pananá
Journal of Immunology Research
 Journal metrics
See full report
Acceptance rate11%
Submission to final decision121 days
Acceptance to publication27 days
CiteScore6.000
Journal Citation Indicator0.560
Impact Factor4.1
 Submit Evaluate your manuscript with the free Manuscript Language Checker

We have begun to integrate the 200+ Hindawi journals into Wiley’s journal portfolio. You can find out more about how this benefits our journal communities on our FAQ.